- Generic name
- Ondansetron
- Strength
- 4 mg/5 ml
- Dosage form
- Syrup
- Manufactured by
- Naafco Pharma PLC.
Setroanaaf Syrup
About Setroanaaf 4 mg/5 ml Syrup
Setroanaaf 4 mg/5 ml is a syrup product of Naafco Pharma PLC. that contains Ondansetron. It can be given to help prevent nausea and vomiting caused by cancer chemotherapy, including repeated courses.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Setroanaaf 4 mg/5 ml Syrup?
Setroanaaf is a syrup from Naafco Pharma PLC., with the generic name Ondansetron. Ondansetron is commonly used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery. Setroanaaf syrup is a liquid anti-emetic medicine containing the generic Ondansetron. The doctor decides the dose and course based on the patient's condition.
Uses of Setroanaaf
It can be given to help prevent nausea and vomiting caused by cancer chemotherapy, including repeated courses. Setroanaaf is used to help prevent nausea and vomiting linked to chemotherapy for cancer, and to prevent and treat nausea and vomiting after an operation. Setroanaaf 4 mg/5 ml syrup is a form of this medicine. The doctor decides if this medicine is suitable for a particular patient.
How to use Setroanaaf
Measure the syrup carefully with a proper measuring device. Measure the liquid with the cap or spoon that comes with the pack. Setroanaaf is taken by mouth. Swallow the syrup with a glass of water. The dose and how often to give it depend on the reason it is being used and will be decided by the doctor. Do not change the dose or stop the medicine without medical advice.
Side effects of Setroanaaf
Unusual reactions such as rash, breathing problems, chest pain, a fast heartbeat or low potassium have been reported. If you experience any unusual symptoms, tell your doctor immediately. Rarely, serious allergic reactions, breathing problems, fast heartbeat, chest pain, low potassium levels, and shortness of breath have occurred. Tell your doctor if you notice any side effect that worries you or does not go away.
Safety and precautions
Tell the doctor before using Setroanaaf syrup if you have ever had an allergic reaction to Ondansetron or to similar anti-sickness medicines, or if you have liver problems. It does not stimulate stomach or bowel movement and should not replace nasogastric suction. Pregnancy and breastfeeding should be discussed with the doctor, as controlled studies in pregnant women are lacking. The doctor will decide if it is suitable for you.
Frequently asked questions
What does Setroanaaf treat?
It can be given to help prevent nausea and vomiting caused by cancer chemotherapy, including repeated courses. Setroanaaf is used to help prevent nausea and vomiting linked to chemotherapy for cancer, and to prevent and treat nausea and vomiting after an operation.
How do I use Setroanaaf correctly?
Measure the syrup carefully with a proper measuring device. Measure the liquid with the cap or spoon that comes with the pack.
What should I watch for while using Setroanaaf?
Unusual reactions such as rash, breathing problems, chest pain, a fast heartbeat or low potassium have been reported. If you experience any unusual symptoms, tell your doctor immediately.
Can I use Setroanaaf in pregnancy or while breastfeeding?
Tell the doctor before using Setroanaaf syrup if you have ever had an allergic reaction to Ondansetron or to similar anti-sickness medicines, or if you have liver problems. It does not stimulate stomach or bowel movement and should not replace nasogastric suction.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.